135 related articles for article (PubMed ID: 28720587)
21. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.
Cognasse F; Aloui C; Anh Nguyen K; Hamzeh-Cognasse H; Fagan J; Arthaud CA; Eyraud MA; Sebban M; Fromont E; Pozzetto B; Laradi S; Garraud O
Transfusion; 2016 Feb; 56(2):497-504. PubMed ID: 26446055
[TBL] [Abstract][Full Text] [Related]
22. [Platelets cytokines and their effects on platelet transfusion].
Cognasse F; Osselaer JC; Garraud O
Transfus Clin Biol; 2007 May; 14(1):69-78. PubMed ID: 17499538
[TBL] [Abstract][Full Text] [Related]
23. [Cumulation and effect of chemokines and CD40L during blood storage--review].
Li YN; Liu ML
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1350-3. PubMed ID: 21129292
[TBL] [Abstract][Full Text] [Related]
24. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
Klüter H; Bubel S; Kirchner H; Wilhelm D
Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
[TBL] [Abstract][Full Text] [Related]
25. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.
Bahar B; Schulz WL; Gokhale A; Spencer BR; Gehrie EA; Snyder EL
Br J Haematol; 2020 Feb; 188(3):465-472. PubMed ID: 31566724
[TBL] [Abstract][Full Text] [Related]
26. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
[TBL] [Abstract][Full Text] [Related]
27. Effects of blood products on inflammatory response in endothelial cells in vitro.
Urner M; Herrmann IK; Buddeberg F; Schuppli C; Roth Z'graggen B; Hasler M; Schanz U; Mehr M; Spahn DR; Beck Schimmer B
PLoS One; 2012; 7(3):e33403. PubMed ID: 22438924
[TBL] [Abstract][Full Text] [Related]
28. Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events.
Hamzeh-Cognasse H; Laradi S; Osselaer JC; Cognasse F; Garraud O
Vox Sang; 2015 Feb; 108(2):205-7. PubMed ID: 25334045
[TBL] [Abstract][Full Text] [Related]
29. Fetal bradycardia following intrauterine platelet transfusion: might elevated levels of donor soluble CD40 ligand play a role?
Yazicioglu HF; Hartwig D; von Witzleben-Schürholz E; Neppert J; Gembruch U
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):868-9. PubMed ID: 15315602
[No Abstract] [Full Text] [Related]
30. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
31. Low incidence of post-transfusion Kell (KEL1) alloimmunisation in patients under 50 years old.
Moncharmont P; Barday G; Benamara H;
Transfus Med; 2020 Feb; 30(1):70-72. PubMed ID: 31769076
[No Abstract] [Full Text] [Related]
32. New insights into allergic transfusion reactions and their causal relationships, pathogenesis, and prevention.
Yasui K; Matsuyama N; Takihara Y; Hirayama F
Transfusion; 2020 Jul; 60(7):1590-1601. PubMed ID: 32441362
[No Abstract] [Full Text] [Related]
33. Can we "terminate" alloimmune platelet transfusion refractoriness?
Vassallo RR; Norris PJ
Transfusion; 2016 Jan; 56(1):19-22. PubMed ID: 26756708
[No Abstract] [Full Text] [Related]
34. The negative secondary test for bacterial contamination: reducing the risk of septic transfusion reactions from platelets.
Tomasulo PA; Jacobs MR
Transfusion; 2017 Aug; 57(8):2054-2055. PubMed ID: 28656692
[No Abstract] [Full Text] [Related]
35. Effect of storage of platelet concentrates in PAS-B, PAS-C, or plasma on transfusion reactions.
van Hout FMA; Middelburg RA; van der Meer PF; Pors A; Wiersum-Osselton JC; Schipperus MR; Kerkhoffs JL; van der Bom JG
Transfusion; 2019 Oct; 59(10):3140-3145. PubMed ID: 31503334
[TBL] [Abstract][Full Text] [Related]
36. Differential protein expression of blood platelet components associated with adverse transfusion reactions.
Aloui C; Barlier C; Claverol S; Fagan J; Awounou D; Tavernier E; Guyotat D; Hamzeh-Cognasse H; Cognasse F; Garraud O; Laradi S
J Proteomics; 2019 Mar; 194():25-36. PubMed ID: 30590131
[TBL] [Abstract][Full Text] [Related]
37. Relationship between expression of CD40-CD40 ligand system and serum cholesterol levels in patients with hypercholesterolemia.
Yan JC; Wu ZG; Li L; Zhong RQ; Kong XT
Chin Med J (Engl); 2004 Jul; 117(7):1101-3. PubMed ID: 15265391
[No Abstract] [Full Text] [Related]
38. Platelet transfusion refractoriness and thrombophagocytosis in an HIV/AIDS patient with hemophagocytic lymphohistiocytosis.
Ma T; Hudgins JP; Vergara-Lluri M; Pham H; Brynes R; Shulman IA
Transfusion; 2020 Oct; 60(10):2176-2177. PubMed ID: 32666517
[No Abstract] [Full Text] [Related]
39. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
Tanaka S; Hayashi T; Tani Y; Hirayama F
Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
[TBL] [Abstract][Full Text] [Related]
40. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia.
Apelseth TO; Hervig T; Wentzel-Larsen T; Petersen K; Reikvam H; Bruserud Ø
Eur Cytokine Netw; 2011 Mar; 22(1):52-62. PubMed ID: 21388914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
